NCT01484509

Brief Summary

Leg artery disease is a common condition in which fatty deposits develop in the blood vessels that supply the legs. Many patients with leg artery disease experience a cramp-like leg pain during walking that is relieved by rest; this is called intermittent claudication. To help determine the severity of leg artery disease, patients may be questioned about how far they can walk before claudication pain forces them to stop. However, this information is usually of limited use because most patients poorly estimate their walking capacity. The investigators have developed a simple questionnaire to help estimate walking capacity in patients with leg artery disease. The purpose of this study is to test the validity and reliability of this questionnaire. By validity, the investigators mean the extent to which the questionnaire measures what it is supposed to measure (walking capacity). By reliability, the investigators mean the extent to which the questionnaire produces the same results over time when completed on two different days. The investigators hypothesise that the investigators simple questionnaire will be valid and reliable.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2011

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 24, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 2, 2011

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

May 15, 2012

Status Verified

November 1, 2011

Enrollment Period

11 months

First QC Date

November 24, 2011

Last Update Submit

May 14, 2012

Conditions

Keywords

walking impairmentclaudicationtreadmillquestionnaire

Outcome Measures

Primary Outcomes (2)

  • Treadmill maximum walking distance

    2 weeks

  • EACH-Q walking questionnaire score

    2 weeks

Secondary Outcomes (4)

  • WIQ walking questionnaire score

    2 weeks

  • Self-reported maximum walking distance

    2 weeks

  • 6-minute maximum walking distance

    2 weeks

  • GPS-measured maximum walking distance

    2 weeks

Study Arms (1)

Intermittent claudication

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with intermittent claudication recruited from hospital clinics

You may qualify if:

  • ankle-brachial pressure index \<0.9 on one or both legs
  • presence of leg artery disease with exertional leg symptoms (claudication)
  • age 18-90 years

You may not qualify if:

  • inability to provide written, informed consent
  • medical conditions that make exercise testing unsafe (e.g. unstable angina)
  • comorbidities that limit walking performance to a greater extent than claudication symptoms
  • unable to complete the tests involved in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sheffield Hallam University

Sheffield, South Yorkshire, S10 2BP, United Kingdom

Location

Sheffield Vascular Institute

Sheffield, South Yorkshire, S5 7AU, United Kingdom

Location

Related Publications (1)

  • Tew G, Copeland R, Le Faucheur A, Gernigon M, Nawaz S, Abraham P. Feasibility and validity of self-reported walking capacity in patients with intermittent claudication. J Vasc Surg. 2013 May;57(5):1227-34. doi: 10.1016/j.jvs.2012.02.073. Epub 2013 Feb 4.

MeSH Terms

Conditions

Intermittent Claudication

Condition Hierarchy (Ancestors)

Peripheral Arterial DiseasePeripheral Vascular DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Garry A Tew, PhD

    Sheffield Hallam University

    PRINCIPAL INVESTIGATOR
  • Pierre Abraham, MD, PhD

    University Hospital of Angers, France

    PRINCIPAL INVESTIGATOR
  • Shah Nawaz, MD

    Sheffield Teaching Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2011

First Posted

December 2, 2011

Study Start

June 1, 2011

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

May 15, 2012

Record last verified: 2011-11

Locations